Sun Genomics gathers $9.25m Series A

Sun Genomics, a direct-to-consumer custom probiotics and gut health company, has raised $9.25 million in Series A funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this